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Objectives: Keloid and hypertrophic scars are abnormal manifestations of
wounds that occur following skin injuries in the form of local proliferation of
fibroblasts and increased production of collagen. There are several ways to cure
these scars; treatment must be selected based on the nature of the scars. In this
clinical trial, two methodsdcryotherapy and intense pulsed light (IPL)dare
compared in the treatment of scars, and the results are presented in terms of
improvement level, complications, and patient satisfaction.
Methods: This clinical trial was conducted in southeastern Iran. The intervention
group included scars that underwent the IPL method and the control group,
which consisted of scars that were subjected to cryotherapy. In both methods,
intralesional corticosteroid injection was administered. To select samples, the
easy sampling method was used. To determine the expected outcomes, the
criteria determined in the Vancouver scar scale were used. Data were analyzed
using the Mix Model, chi-square test, and t test.
Results: In this study, 166 samples of keloid and hypertrophic scars were cured
using two methods (Cryotherapy, 83; IPL, 83). The recovery rate was higher in
the Cryotherapy group than in the IPL group (p > 0.05), and the incidence of
complications was also higher in the Cryotherapy group (14.5% vs. 12%). More-
over, patients were more satisfied, although not significantly so, with the cryo-
therapy method (p Z 0.09).
Conclusion: Both methods were highly successful in curing scars; participants
were totally satisfied with both methods.ermatology, Afzalipoor Hospital, Kerman University of Medical sciences, Kerman, Iran.
(A. Rezazadeh).
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Keloid and hypertrophic scars are abnormal mani-
festations of wounds that occur following skin injuries
in the form of local proliferation of fibroblasts and
increased production of collagen. These scars often tend
to occur in places that are under pressure, but some body
organs such as the ear lobules, which are low-pressure
areas, are also disposed to keloid scars [1,2].
Keloid and hypertrophic scars occur for different
reasons including skin injuries, burns, surgery, in-
jections (vaccine, tattoos) and dermatitis (acne vulgaris,
bites) [3]. Among them, deep burns are reported to be
the main cause of keloid scars [4]. Moreover, there are
several reports of keloid manifestation during or after
puberty and after menopause and also of occurrence or
enlargement of keloid during pregnancy [5].
Several studies have reported that hypertrophic scars
occur in 1.5e4.5% of the general public [2]. There are
numerous ways to cure both scars [e.g., surgery, silicone
coating, and compressing the scar to reduce the size of
the lesion, interferon, bleomycin, and 5-fluorouracil (5-
Fu) intralesional injection, corticosteroid intralesional
injection, cryotherapy and intense pulsed light (IPL)
with/without corticosteroid intralesional injection]
[2,3,6e9]; methods must be selected based on the type
and cause of scarring, recovery rate, recurrence rate, and
complications.
Cryotherapy is one of the common methods used to
cure scars. The recovery rate in scars treated with
cryotherapy is reported to be 76%, with an average of 20
therapeutic sessions held once in 2 weeks [10]. Although
this method is satisfactory in terms of recovery, its main
shortcoming is the length of the treatment period.
Studies have shown that IPL is better than cryotherapy;
in addition to desirable recovery, IPL requires fewer
therapeutic sessions to achieve good results, is more
flexible, and can be used in different skin treatments
[11]. Moreover, IPL treatment is not invasive and has
few complications that can be relieved by cooling the
location and using anesthetic creams. Making use of
special sheets, we can prevent the skin around the lesion
from being exposed to the sunlight [6].
In a study carried out by Erol et al [1] in 2008 on 109
patients (with hypertrophic scars) who were treated with
IPL, clinical improvement in scar appearance was re-
ported in 99.5% of patients. Myers et al [12] cured 107
patients with IPL; the recovery rate was 55% [7]. In a
study by Han et al [13], clinical recovery was 100% with
an average of 5.3 therapeutic sessions on 22 patients.
According to the researchers’ experience, the preva-
lence of hypertrophic and keloid scars is relatively high
in southeast Iran (Kerman), and the common method
(cryotherapy) used in this regard is not satisfactory
because of the long treatment period, lack of treatment
completion, complications, and patient dissatisfaction.Thus, in this clinical trial researchers compared the
overall recovery rate, recovery rate in terms of number
of treatment sessions and features of scars, complica-
tions, and level of patient satisfaction; accordingly,
several suggestions were proposed.2. Materials and methods
This clinical trial was carried out in southeastern Iran
in 2012e2013. The intervention group included scars
that were treated using the IPL method with cortico-
steroid intralesional injection, and the control group
consisted of scars that were treated using the cryo-
therapy method with corticosteroid intralesional injec-
tion. The inclusion criteria included all keloid or
hypertrophic scars (scars with appearance of more than
1-year duration and scars that extend beyond the wound
of margin) caused by trauma, surgery, burns, acne, and
thermal or chemicals burns. The exclusion criteria
included complications considered unacceptable by the
patients.
Intervention in IPL (MED FLASH II; Manufacturer,
Italy) was performed using 450e1,200 nm filters,
30e40 J/cm2 fluence, pulse duration of 2.1e10 ms, and
pulse delay of 10e40 ms. The normal skin around the
lesion was protected by a covering (protection) device
attached to the laser handle. In the control group,
cryotherapy with liquid nitrogen was performed for
10 seconds on the lesion. In both methods, 1 mg/cm2
triamcinolone acetonide injection mixed with lidocaine
(50:50 ratio) was used. The interval between therapeutic
sessions was 3 weeks with a maximum of eight treat-
ment times.
The required sample size for each group was 73 pa-
tients. Because the participants were patients who were
referred to the department of dermatology in Afzalipour
Hospital in Kerman, Iran, simple sampling (census
method) was used. As the study started, the first sample
was allocated to the intervention group and the second
sample to the control group; next, samples were allo-
cated to both groups in the same manner.
This study was approved by the Ethics Committee of
Kerman University of Medical Sciences with the code
91/140. Prior to the study, research conditions and
treatment procedures were explained to all potential
participants; individuals were included after they have
provided written informed consent to participate in the
study. Participants were also free to leave the study in
every stage of the research. In addition, studies indicated
that complications of the intervention method did not
exceed those of the routine method (Cryotherapy). This
investigation was designed as a single blind study.
Neither evaluators nor patients knew what type of scar
or which patient was allocated to the intervention or
control groups. Details of all patients were recorded in a
Comparing two cryotherapy and IPL methods 315form; to prevent exclusion of patients, some guidelines
were suggested including suitable advice in the first
session and telephone follow-ups.
To gather information, a checklist was designed; it
included the variables of age, sex, scar occurrence age,
length of scar, causes of scar, history of treatment, scar
clinical status in terms of vascularity, pigmentation,
pliability, height, clinical improvement, color improve-
ment, scar height, and satisfaction of patients with the
therapeutic methods. To determine the expected out-
comes of the research (complete recovery rate, recovery
rate in poor, average, good and excellent levels, recov-
ery rate in terms of number of treatment sessions and
complications), criteria determined in the Vancouver
scar scale [10] were used. Also, to determine features of
the lesion, the criteria proposed in a study by Erol et al
[1] were used.
For classification of treatment results, recovery of up
to 25% was considered poor; 26e50%, average;
51e75%, good; and more than 75%, excellent. More-
over, scars with 100% recovery were considered com-
plete recovery.
SPSS ver. 20 (Chicago: SPSS Inc) was used to include
and analyze data; data were analyzed using chi-square
test and t test. It should be noted that the significance
level of the test was considered equal to or less than 5%.3. Results
In this study, 166 samples of colloid and hypertrophic
scars were cured using two methods (Cryotherapy, 83;
IPL, 83). The average age of participants in the Cryo-
therapy group and the IPL group was 30.9  14.6 and
32.5  18.4 years, respectively. According to the results
of the t test, the differences were not statistically sig-
nificant (p Z 0.5). Most samples (72.3%) came from
women.
Table 1 shows that distribution of samples is not
statistically different in both Cryotherapy and IPL
groups in terms of the place and cause of scars, vascu-
larity, and pigmentation, whereas it is different in terms
of other variables mentioned in the sample distribution
table.
Improvement of clinical status, improvement of
color, and improvement of height were observed more
in the cryotherapy method than in IPL; however, these
differences are trivial and are not statistically significant.
The average number of therapeutic sessions in IPL and
Cryotherapy groups was 5.3 and 4.6, respectively. This
difference is not statistically significant (p Z 0.05).
Complications in the Cryotherapy group exceeded those
of the IPL group (14.5% vs. 12%). Moreover, satisfac-
tion with cryotherapy was nonsignificantly higher
compared with IPL (p Z 0.09). Excellent response to
treatment (recovery of more than 75%) was higher in
Cryotherapy than in IPL (p Z 0.5). It should be notedthat the most common complication of both methods
was hyperpigmentation (Table 2).
In Table 3, the rate of complete recovery was not
statistically different in both methods in terms of sex.
The highest recovery rate in the Cryotherapy group was
in the age groups of below 10 and 21e40 years,
respectively, whereas in the IPL group it was observed
in the age groups of 11e20 and 21e40 years. The
highest recovery rate in the Cryotherapy group was
related to leg and hand scars, whereas it was related to
arm and abdomen in the IPL method. The chest area had
the lowest recovery rate (14.9% scars) in the Cryo-
therapy method. However, IPL could cure 76.5% of
scars in this area. Concerning causes of scars, no sig-
nificant difference was observed between both methods.
Cryotherapy could treat 91.7% of scars caused by burns,
whereas IPL cured only 50% of them. Furthermore,
more purple vascularity scars were cured using cryo-
therapy than with IPL (92.3% vs. 53.8%).
Table 3 shows that the rate of complete recovery
(treatment result) is not statistically significant in cryo-
therapy method in terms of scar clinical status con-
cerning pigmentation (p Z 0.2). However, these
differences are significant (p Z 0.003) in the IPL
method. In the IPL method, response to treatment of
hyperpigmentation scars is lower than that of other
pigmentation scars (hypopigmentation and mixed). In
terms of scar clinical status concerning pliability, the
rate of complete recovery is statistically different in
these two methods (p < 0.001); the response of both
methods to yielding and supple scars was excellent.
Moreover, response to treatment of contracture scars
was better in IPL than in cryotherapy (50% vs. 0%) and
cryotherapy was better in curing rope scars than the IPL
method (100% vs. 0%). Response to treatment of scars
with height of more than 5 mm was low in both methods
(Cryotherapy, 50%; IPL, 43.2%). It should be noted that
response to treatmentdin terms of scar heightdis sta-
tistically different in cryotherapy and IPL methods
(p Z 0.007 and p <0.001, respectively).4. Discussion
In this clinical trial, the efficiency of two method-
sdcryotherapy and IPLdalong with corticosteroid in-
jection was compared in curing keloid and hypertrophic
scars. It was shown that both methods were highly
successful in curing these scars, and the participants
were completely satisfied with both methods. However,
complications of cryotherapy exceeded those observed
in IPL. The average number of therapeutic sessions in
IPL was higher than the other method (although not at a
very significant level).
In a study carried out by Kontes et al [14] on 83
patients who underwent the IPL þ intra lesional corti-
costeroid (ILC) method in 2002, the recovery rate in all
Table 1. Comparison of demographic data and basic variables in the samples studied.
Variables
Cryotherapy IPL
pn (%) n (%)
Sex Male 13 (15.7) 33 (39.8) < 0.001
Female 70 (84.3) 50 (60.2)
Age group  10 1 (1.2) 7 (8.4) 0.01
11e20 20 (24.1) 17 (20.5)
21e40 44 (53) 46 (55.4)
41e60 14 (16.9) 4 (4.8)
 61 4 (4.8) 9 (10.8)
Member of overtaken Chest 19 (22.9) 17 (20.5) 0.9
Abdomen 7 (8.4) 6 (7.2)
Hand 12 (14.5) 14 (16.9)
Shoulder 17 (20.5) 14 (16.9)
Leg 7 (8.4) 7 (8.4)
Arm 21 (25.3) 25 (30.1)
Cause of scarring Surgery 11 (13.3) 12 (14.5) 0.1
Acne 38 (45.8) 23 (27.7)
Trauma 22 (26.5) 32 (38.6)
Burn 12 (14.5) 16 (19.3)
Vascularity NL 0 0 0.8
Pink 23 (27.7) 26 (31.3)
Red 47 (56.6) 44 (53)
Purple 13 (15.7) 13 (15.7)
Pigmentation NL 0 0 0.2
Hypopigmentation 11 (13.3) 6 (7.2)
Mixed 40 (48.2) 36 (43.4)
Hyperpigmentation 32 (38.6) 41 (49.4)
Pliability NL 0 0 0.004
Supple 4 (4.8) 1 (1.2)
Yielding 26 (31.3) 8 (9.6)
Firm 46 (55.4) 63 (75.9)
Contracture 4 (4.8) 4 (4.8)
Rope 3 (3.6) 7 (8.4)
Height Flat 0 0 0.01
< 2 mm 28 (33.7) 16 (19.3)
2e5 mm 35 (42.2) 30 (36.1)
> 5 mm 20 (24.1) 37 (44.6)
History of treatment Yes 8 (9.6) 20 (24.1) 0.01
No 75 (90.4) 63 (75.9)
Total 83 83 d
IPL Z intense pulsed light; NL Z normal.
316 S.S. Meymandi, et alpatients was more than 75% and the lesion size reduc-
tion was more than 50% [14]; this is in line with the
results of the present study. In another study conducted
by Erol et al [1] in 2008, 109 patients with hypertrophic
scars were treated with IPL; excellent response, mod-
erate response, and poor response to treatment were
31.2%, 34%, and 9.1%, respectively. The efficiency of
IPL in the treatment of scars was lower than its effi-
ciency in the present study, which used IPL plus intra-
lesional corticosteroid injection [1]. Han et al [13] cured
22 patients with keloid and hypertrophic scars caused by
surgery using IPL in 2007; 100% of patients achieved
clinical recovery. It was better than the results of ourstudy. Myers et al [12] reported that the recovery rate of
107 patients who suffered from various skin disorders
was 55% with the IPL method, which is significantly
lower than that recorded in the present study. This dif-
ference can be attributed to the fact that Myers et al [12]
did not use IPL and intralesional corticosteroid injection
simultaneously.
Using cryosurgery plus intralesional corticosteroid
injection, Boutli-Kasapidou et al [15] cured eight pa-
tients with keloid scars caused by surgery. Complete
recovery and good recovery (50e75%) were 13% and
74%, respectively. Concerning the cryotherapy method,
recovery at good level was 17% and 50% for scars
Table 2. Comparison of cure rate in samples studied.
Variables Cryotherapy IPL p
Improvement of clinical (%) 91.5 89.3 0.5
Improvement of color (%) 91.5 89 0.4
Improvement of height (%) 91.4 89.3 0.5
Average number of treatment sessions (n) 4.6 5.3 0.05
Incidence of Complications (n/%) 12/14.5 10/12 0.4
Satisfaction of treatment method (%) 93.2 88.8 0.09
Kind of complications
(n)





Hyperpigmentation and ulcer 1 0




IPL Z intense pulsed light.
Comparing two cryotherapy and IPL methods 317caused by acne and scars resulting from burns, respec-
tively [15]; these are much lower than the results of our
study (in our study, 78.9% of scars caused by acne and
91.7% of scars caused by burns recovered completely).
In a study by Zouboulis et al [16] in 1992, 93 patients
with keloid and hypertrophic scars were treated using
cryosurgery without injection. Excellent recovery, good
recovery, and treatment failure were 32.35%, 29%, and
9.75%, respectively [16]; the efficiency of cryotherapy
was lower than that recorded in the present study. The
desirable result observed in the present study can be
attributed to the simultaneous use of cryotherapy and
intralesional corticosteroid injections.
The results of a study by Layton et al [17], who
treated 11 cases of colloid scars, showed that cryo-
therapy was effective in lesions with high vascularity
[17]; this is in line with the results of the present study
(pink). Moreover, Layton et al [17] showed that
response to treatment of scars and lesions on the chest is
less than the response to lesions in other areas, which is
in contrast with our findings.
In a study by Atiyeh [18] in 2007, the recovery rate
was 51e74% after two times of treatment with cryo-
therapy, and the most common complications of cryo-
therapy were hypopigmentation, skin atrophy, and
hyperpigmentation [18]. It was shown in a study con-
ducted by Kelly [19] that cryotherapy with intralesional
corticosteroids injection resulted in the recovery of 84%
of patients; however, some patients complained about
pain, slow recovery, and hypopigmentation [19]. In
Zouboulis et al’s study [20], the rate of recovery in scars
was 75% using cryotherapy plus intralesional injection.
However, hypopigmentation was observed in 12% of
patients, and local necrosis, edema, and wound infection
were observed in a few patients [20]. In a study carriedout by Bloemen et al [10], the recovery rate of 76%
(from scars) was at a good level, in which the treatment
consisted of cryotherapy plus intralesional corticoste-
roids injection. Nevertheless, several complications such
as skin atrophy, hypopigmentation, and telangiectasia
were observed [10].
In his study, Erol et al [1] treated 109 patients with
hypertrophic scars using IPL without injection; three
patients reported purpura and one patient reported hy-
perpigmentation. However, no purpura was observed in
our research. In their study, Kontes et al [14] observed
blisters and crust following IPL plus injection, whereas
no blisters and crust were observed in our study. In the
study by Manuskiatti and Fitzpatrick [21], complications
of intralesional steroid injection (e.g., hypo-
pigmentation, telangiectasia, and atrophy) were reported
in 50% of treated lesions; hyperpigmentation was the
most common complication in our study, which used
intralesional injection in both methods. Myers et al [12]
used IPL to cure 107 patients with skin disorders. Of this
total, six patients reported several complications; in
addition to erythema and minor discomfort, one partic-
ipant reported blister, one reported vesicol, and two
reported edema. In our study, no erythema, blister, or
vesicol was observed in treatment with IPL.
Shaffer et al [22] stated that the objective of treating
scars depended on the beauty needs of patients and their
disabilities. They also mentioned that in spite of the
efficiency of cryotherapy in removing keloid scars, its
side effectsdespecially hypopigmentationdmust be
taken into account. Generally, curing keloid and hy-
pertrophic scars is controversial and has largely no fixed
protocol. So far, various methods (including silicon
sheets, surgery, surgery with radiation therapy, intra-
dermal injections of interferon alpha, PDL laser, 5-Fu
Table 3. Comparison of complete cure in the samples studied.
Variables
Cryotherapy IPL
N (%) p N (%) p
Sex Male 11 (84.6) 0.3 29 (87.9) 0.06
Female 56 (80) 31 (62)
Age group (y)  10 1 (100) 0.05 2 (28.6) < 0.001
11e20 15 (75) 17 (100)
21e40 39 (88.6) 33 (71.7)
41e60 8 (57.1) 2 (50)
 61 4 (100) 6 (66.7)
Member of overtaken Chest 10 (14.9) 0.04 13 (76.5) 0.001
Abdomen 6 (85.7) 5 (83.3)
Hand 11 (91.7) 7 (50)
Shoulder 15 (88.2) 9 (64.3)
Leg 7 (100) 3 (42.9)
Arm 18 (85.7) 23 (92)
Cause of scarring Surgery 7 (63.6) 0.3 8 (66.7) 0.08
Acne 30 (78.9) 17 (73.9)
Trauma 19 (86.4) 27 (84.4)
Burn 11 (91.7) 8 (50)
Vascularity NL d 0.2 d 0.02
Pink 21 (91.3) 24 (92.3)
Red 34 (72.3) 29 (65.9)
Purple 12 (92.3) 7 (53.8)
Pigmentation NL d 0.2 d 0.003
Hypopigmentation 11 (100) 5 (83.3)
Mixed 34 (85) 31 (86.1)
Hyperpigmentation 22 (68.8) 24 (58.5)
Pliability NL d < 0.001 d < 0.001
Supple 4 (100) 1 (100)
Yielding 23 (88.5) 8 (100)
Firm 37 (80.4) 49 (77.8)
Contracture 0 2 (50)
Rope 3 (100) 0
Height (mm) Flat d 0.007 d < 0.001
< 2 27 (96.4) 16 (100)
2e5 30 (85.7) 28 (93.3)
> 5 10 (50) 16 (43.2)
History of treatment Yes 7 (87.5) 0.7 12 (60) 0.1
No 60 (80) 48 (76.2)
IPL Z intense pulsed light.
318 S.S. Meymandi, et alintradermal injection, cryosurgery, corticosteroid intra-
dermal injection) have been used to treat these scars
[1,13,21,23].
Intralesional corticosteroid injection is the first ther-
apeutic step among physicians. Increasing vasocon-
striction in scars, corticosteroids inhibit inflammation
and mitosis, decrease scar volume significantly, soften
it, reduce its height, and reduce symptoms such as
itching and pain [1,13,21,23].
Intralesional corticosteroid injection used along with
both methods in the present research is one of the main
methods in the treatment of keloid and hypertrophic
scars, and can be used alone or in combination with
other methods. Corticosteroid softens colloids but is notable to narrow the scar or remove it completely. Intra-
lesional corticosteroid injection decreases fibroblast
proliferation, collagen synthesis, and glycosamino-
glycan, and inhibits the production of inflammatory
mediators [1,13,21,23].
According to electronic search conducted in this
study as well as the authors’ knowledge, lack of access
to similar studies was one of the limitations of this
research; thus, we could not compare the results of this
study in terms of some variables. Another limitation of
this study was the lack of investigation in terms of
duration of scars in response to treatment. Nonsimilarity
of some demographic characteristics and basic clinical
status in both methods and the small sample size in
Comparing two cryotherapy and IPL methods 319terms of various layers of studied variables were further
limitations of the present study. Therefore, necessary
conditions have not been provided that would allow us
to comment on the results of this research definitely and
appropriately.
This study has shown that making use of a combination
of intralesional corticosteroid injection and IPL or cryo-
therapy is effective and desirable in the treatment of keloid
and hypertrophic scars and has no significant complica-
tions.Moreover, according to the results of this research, it
can be stated that therapeutic method is selected based on
patient age, causes of scar, scar area, scar clinical status
(vascularity, pigmentation, pliability and height), patient’s
opinion, and patient’s economic conditions.Author contribution
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